Claim
descriptive

The most important human study on this brain ultrasound tech showed it worked better than a fake treatment for shaking hands, and it was published in one of the world’s top medical journals.

Claim Context

Scientific statement

The top-cited human clinical trial in MRgFUS research is a 2016 randomized controlled trial published in the New England Journal of Medicine demonstrating significant improvement in essential tremor symptoms after focused ultrasound thalamotomy compared to sham treatment.

Original statement
The next two articles in the top 100 list, published in the New England Journal of Medicine, described the clinical application of MRgFUS in essential tremors... Another article published in 2016, titled 'A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor,' was a multicentre trial that confirmed the efficacy of focused ultrasound thalamotomy.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses
In Evidence

That this 2016 RCT is the most frequently cited and influential clinical trial in MRgFUS research for essential tremor.

A systematic review of all MRgFUS clinical trials (1998–2024), analyzing citation counts, clinical guidelines citations, and impact on subsequent trials to identify the most influential human trial.

2
Randomized Controlled Trials

That focused ultrasound thalamotomy is superior to sham treatment for essential tremor in a controlled setting.

A double-blind, multicenter RCT of 100+ patients with medication-refractory essential tremor, randomized to MRgFUS thalamotomy vs. sham (placebo sonication), with primary outcome: change in Fahn-Tolosa-Marin Tremor Rating Scale at 12 months.

3
Cohort Studies

That patients undergoing this procedure have sustained tremor improvement in real-world clinical practice.

A prospective cohort of 200+ patients with essential tremor treated with MRgFUS thalamotomy across 10 centers, tracking tremor scores, quality of life, and adverse events over 5 years.

Sign up to see full verdict